Welcome to PanGIA Biotech, a leading biotechnology company at the forefront of true liquid biopsy technology. We are dedicated to transforming disease and cancer detection through our innovative and groundbreaking solutions. With our expertise and commitment to research, we aim to make a significant impact by empowering patients and healthcare providers with powerful detection tools.

At PanGIA, our team believes in the power of the true liquid biopsy. Our team of scientists, researchers, and industry experts have developed cutting-edge methods to detect and analyze cancer-related biomarkers in urine. By harnessing the potential of the true liquid biopsy, we can provide accurate, non-invasive, and personalized diagnostic solutions for early cancer detection, treatment selection, and monitoring.

We help patients, clinicians, and payers looking for: